Jafron Biomedical Co.,Ltd.

¥20.58As of Sun 8 Nov 2026, 12:00 UTC
SZSE:300529Healthcare
Country China
PE (Fwd) •••
TSR 10Y CAGR (2.12%)
Div yield 2.53%
ROE 18.53%
Medical Devices
Beta (5Y) 0.28
PE TTM 24.49
TSR TTM 3.90%
Mkt cap ¥15.94B
ROIC 31.23%
SE Grade™
Value
Quality
Moat
Consensus
Reference
¥25
19.29%
(38.81%)
Hold 1|10|10|1|9
4Q25
1Q26
2Q26
3Q26
Earnings per share¥
0.23
0.22
0.23
0.24
9.25%
(1.49%)
(3.27%)
5.65%
Revenue¥B
1.089
1.139
1.145
1.200
(7.14%)
(0.16%)
0.94%
8.07%
Peers (US$2.389B)
Cap (US$)
PE
2.553B
26.82x
2.351B
31.01x
Capital
TTM
5Y
10Y
Leveragex
0.445
3.440
2.253
EBIT/Intx
3.703
0.308
0.301
Own earn%
31.84
(38.34)
(44.82)
Sh yield%
30.63
35.49
35.28
Owners
Insiders/Inst%
11.56
42.00
Short interest%
1.11
SBC / revenue%
0.52
Record
10Y
Profitable years
10/10
Revenue growth years
10/10
EPS growth years
10/10
Dividend streakyrs
19
Op margin range%
18–25
$1 testx
—
Incr. ROIC%
5